Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Chronic pain management

Cannabis cuts opioid use in 90% of cases, study finds

Study data published in the Journal of Psychoactive Drugs show that cannabis use can help reduce the amount of opioids people take.

Almost nine out of ten adults who bought cannabis for pain relief, and who had also used opioids in the previous six months, had either reduced or stopped opioid use as a consequence, results of a study published in the Journal of Psychoactive Drugs (2 July 2019) show.

Customers presenting at two retail cannabis dispensaries in Colorado, where cannabis is legal for both medical and recreational use, were invited by store staff to take part in the survey. Respondents who possessed a medical marijuana card, which allows the holder to purchase more of the drug than those without, were excluded.

Of the 1,000 respondents remaining, 647 said they used cannabis for pain relief. Of those, 319 (49%) said that had used opioid analgesics, including oxycodone, hydrocodone, tramadol or morphine, in the past six months. Of those 319, 281 (88%) said they had either stopped or reduced opioid use over that time period as a result.

As part of the survey, customers were asked whether they were recreational users, medical card holders or both. A limitation of the study, the authors acknowledge, was that the survey did not ask respondents for “their primary reason for taking cannabis” and “respondents may [cannabis] use for both symptom relief and pleasurable psychoactive effects”.

The survey was developed by the dispensary company “to elicit customer feedback and understand customers’ use of cannabis for symptom relief”.

Gwen Wurm, assistant professor of clinical paediatrics at the University of Miami’s Miller School of Medicine and the paper’s lead author, said that the figure for those who reported stopping or reducing opioid use “corresponds with other research on medical cannabis patients in the literature”.

“Unfortunately, we don’t have specific data on prescriptions or on how much or what type of cannabis [was bought]”, she added. “What we need is more research in this area to be able to recommend effective treatments for patients.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206744

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now
  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.